Literature DB >> 21311935

The effectiveness of methicillin-resistant Staphylococcus aureus colonisation screening in asymptomatic healthcare workers in an Irish orthopaedic unit.

S P Edmundson1, K M Hirpara, D Bennett.   

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) infections are associated with increased mortality, costs and length of stay compared to non-MRSA infections. This observational 4-year study analyses the impact of screening and treating orthopaedic healthcare workers for MRSA colonisation. A total of 1,011 swabs were taken from 566 healthcare workers. Positive healthcare workers were treated with topical mupirocin to both anterior nares. The prevalence of MRSA colonisation on initial testing was 4.77%. The rate of positive MRSA colonisation of those tested on more than one occasion fell from 5.88% to 2.71% (p = 0.055) on subsequent screening. All healthcare workers receiving treatment were successfully cleared of colonisation; however, some required more than one course of treatment. These results show that there could be a role for screening and treating orthopaedic staff for MRSA colonisation as part of a strategy to reduce the prevalence of MRSA infections in orthopaedic units.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21311935     DOI: 10.1007/s10096-011-1192-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  Methicillin resistance in staphylococci.

Authors:  M P JEVONS; A W COE; M T PARKER
Journal:  Lancet       Date:  1963-04-27       Impact factor: 79.321

2.  Methicillin-resistant Staphylococcus aureus in an Irish orthopaedic centre: a five-year analysis.

Authors:  S J Roche; D Fitzgerald; A O'Rourke; J P McCabe
Journal:  J Bone Joint Surg Br       Date:  2006-06

3.  Surgical site infection with methicillin-resistant Staphylococcus aureus after primary total hip replacement.

Authors:  R J Walls; S J Roche; A O'Rourke; J P McCabe
Journal:  J Bone Joint Surg Br       Date:  2008-03

4.  When should healthcare workers be screened for methicillin-resistant Staphylococcus aureus?

Authors:  M P Lessing; J Z Jordens; I C Bowler
Journal:  J Hosp Infect       Date:  1996-11       Impact factor: 3.926

Review 5.  Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities.

Authors:  J E Coia; G J Duckworth; D I Edwards; M Farrington; C Fry; H Humphreys; C Mallaghan; D R Tucker
Journal:  J Hosp Infect       Date:  2006-04-03       Impact factor: 3.926

Review 6.  Epidemiology of methicillin-resistant staphylococci in Europe.

Authors:  S Stefani; P E Varaldo
Journal:  Clin Microbiol Infect       Date:  2003-12       Impact factor: 8.067

7.  Role of healthcare workers in outbreaks of methicillin-resistant Staphylococcus aureus: a 10-year evaluation from a Dutch university hospital.

Authors:  Hetty E M Blok; Annet Troelstra; Titia E M Kamp-Hopmans; Ada C M Gigengack-Baars; Christina M J E Vandenbroucke-Grauls; Annemarie J L Weersink; Jan Verhoef; Ellen M Mascini
Journal:  Infect Control Hosp Epidemiol       Date:  2003-09       Impact factor: 3.254

8.  Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The Mupirocin Collaborative Study Group.

Authors:  B N Doebbeling; D L Breneman; H C Neu; R Aly; B G Yangco; H P Holley; R J Marsh; M A Pfaller; J E McGowan; B E Scully
Journal:  Clin Infect Dis       Date:  1993-09       Impact factor: 9.079

9.  Early infection after hip fracture surgery: risk factors, costs and outcome.

Authors:  C Edwards; A Counsell; C Boulton; C G Moran
Journal:  J Bone Joint Surg Br       Date:  2008-06

10.  Mupirocin ointment with and without chlorhexidine baths in the eradication of Staphylococcus aureus nasal carriage in nursing home residents.

Authors:  C Watanakunakorn; C Axelson; B Bota; C Stahl
Journal:  Am J Infect Control       Date:  1995-10       Impact factor: 2.918

View more
  6 in total

1.  Emergence of hospital- and community-associated panton-valentine leukocidin-positive methicillin-resistant Staphylococcus aureus genotype ST772-MRSA-V in Ireland and detailed investigation of an ST772-MRSA-V cluster in a neonatal intensive care unit.

Authors:  Gráinne I Brennan; Anna C Shore; Suzanne Corcoran; Sarah Tecklenborg; David C Coleman; Brian O'Connell
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

Review 2.  Prevention of fracture-related infection: a multidisciplinary care package.

Authors:  Willem-Jan Metsemakers; Jolien Onsea; Emilie Neutjens; Ester Steffens; Annette Schuermans; Martin McNally; Stefaan Nijs
Journal:  Int Orthop       Date:  2017-08-22       Impact factor: 3.075

Review 3.  Staphylococcus aureus screening and decolonization in orthopaedic surgery and reduction of surgical site infections.

Authors:  Antonia F Chen; Charles B Wessel; Nalini Rao
Journal:  Clin Orthop Relat Res       Date:  2013-03-06       Impact factor: 4.176

Review 4.  MRSA carriage among healthcare workers in non-outbreak settings in Europe and the United States: a systematic review.

Authors:  Madeleine Dulon; Claudia Peters; Anja Schablon; Albert Nienhaus
Journal:  BMC Infect Dis       Date:  2014-07-03       Impact factor: 3.090

5.  Mupirocin in the Treatment of Staphylococcal Infections in Chronic Rhinosinusitis: A Meta-Analysis.

Authors:  Jong Seung Kim; Sam Hyun Kwon
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

6.  General Assembly, Prevention, Operating Room - Personnel: Proceedings of International Consensus on Orthopedic Infections.

Authors:  Andrea Baldini; Kier Blevins; Daniel Del Gaizo; Oliver Enke; Karan Goswami; William Griffin; Pier Francesco Indelli; Toby Jennison; Eustathios Kenanidis; Paul Manner; Robin Patel; Teija Puhto; Parag Sancheti; Rahul Sharma; Rajeev Sharma; Rjajendra Shetty; Rami Sorial; Naasha Talati; T David Tarity; Kevin Tetsworth; Christos Topalis; Eleftherios Tsiridis; Annette W-Dahl; Matthew Wilson
Journal:  J Arthroplasty       Date:  2018-10-22       Impact factor: 4.757

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.